TARA icon

Protara Therapeutics

36 hedge funds and large institutions have $43.7M invested in Protara Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

12% less funds holding

Funds holding: 4136 (-5)

37% less capital invested

Capital invested by funds: $69.3M → $43.7M (-$25.6M)

45% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 11

Holders
36
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$168K
Puts
$11K
Net Calls
Net Calls Change

Top Buyers

1 +$779K
2 +$765K
3 +$523K
4
Renaissance Technologies
Renaissance Technologies
New York
+$446K
5
Goldman Sachs
Goldman Sachs
New York
+$164K

Top Sellers

1 -$6.75M
2 -$3.41M
3 -$725K
4
E
Ergoteles
New York
-$172K
5
Millennium Management
Millennium Management
New York
-$169K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$17.7M
2
$3.32M
3
$3.11M
4
$3.02M
5
$2.92M
6
$2.4M
7
$1.45M
8
$1.38M
9
$1.17M
10
$1.08M
11
$906K
12
$802K
13
$779K
14
$726K
15
$546K
16
$328K
17
$306K
18
$252K
19
$184K
20
$166K
21
$158K
22
$154K
23
$124K
24
$119K
25
$110K